Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Phibro Animal Health (PAHC) Revenue (2016 - 2025)

Historic Revenue for Phibro Animal Health (PAHC) over the last 14 years, with Q4 2025 value amounting to $373.9 million.

  • Phibro Animal Health's Revenue rose 2090.43% to $373.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.5 billion, marking a year-over-year increase of 3238.87%. This contributed to the annual value of $1.3 billion for FY2025, which is 2736.97% up from last year.
  • Phibro Animal Health's Revenue amounted to $373.9 million in Q4 2025, which was up 2090.43% from $363.9 million recorded in Q3 2025.
  • Phibro Animal Health's Revenue's 5-year high stood at $378.7 million during Q2 2025, with a 5-year trough of $211.7 million in Q1 2021.
  • Moreover, its 5-year median value for Revenue was $252.5 million (2023), whereas its average is $270.2 million.
  • As far as peak fluctuations go, Phibro Animal Health's Revenue plummeted by 50.4% in 2023, and later soared by 3972.67% in 2025.
  • Quarter analysis of 5 years shows Phibro Animal Health's Revenue stood at $232.7 million in 2021, then grew by 5.13% to $244.6 million in 2022, then increased by 2.17% to $249.9 million in 2023, then grew by 23.73% to $309.3 million in 2024, then grew by 20.9% to $373.9 million in 2025.
  • Its Revenue stands at $373.9 million for Q4 2025, versus $363.9 million for Q3 2025 and $378.7 million for Q2 2025.